US EditionRo to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
- Ro is working to make weight loss drug Zepbound more affordable
- The collaboration with Eli Lilly aims to achieve this goal
- Ro and Eli Lilly focus on offering lower-price vials
11 Articles
11 Articles
Eli Lilly will start offering vials of her best-selling weight loss drug, Zepbound, through Ro's telehealth platform this Wednesday, providing patients with another way to access a more affordable version of the injection. Previously, patients could only get vials of Zepbound, which are normally sold in a self-injecting pen, through Lilly's direct-sell site to Lilly's consumer, LillyDirect. To reinforce the supplies of popular drugs amid a natio…
Eli Lilly is partnering with Ro to make it easier than ever to get Zepbound
Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound available on telehealth platform Ro. Starting today, consumers can get an online diagnosis, prescription services, and Zepbound vials delivered to straight their homes — all via Ro.Read more...
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
